Oscar Health Inc. stock rises amid sector rotation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 16 2025
0mins
Source: NASDAQ.COM
Oscar Health Inc. shares rose by 8.33% as the stock crossed above its 5-day SMA, indicating a positive shift in momentum.
The increase in Oscar Health's stock price comes amid sector rotation, as investors are moving funds into healthcare stocks despite the overall decline in the Nasdaq-100 index. This shift suggests a growing confidence in the healthcare sector, which may be driven by recent developments in health insurance policies and increased demand for telehealth services.
This upward movement in Oscar Health's stock could signal a potential recovery for the company, attracting more investors looking for opportunities in the healthcare market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to fall
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 31.440
Low
11.00
Averages
15.75
High
25.00
Current: 31.440
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare Sector Rally: Raymond James Picks New Stars
- Healthcare Sector Rally: The healthcare sector surged over 6% in June as investors shifted towards defensive plays, reflecting strong interest in healthcare stocks amid poor performance in tech stocks.
- UnitedHealth Group's Strong Performance: UnitedHealth's stock has risen 28%, with expectations for near-term gains from its earnings report on July 16, driven by moderating medical cost trends and improving insurance margins.
- Dividend Growth and Analyst Ratings: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, with 80% of analysts rating it a buy, although the consensus price target suggests a potential 3% decline over the next year.
- Emerging Opportunities for Janus Living: Janus Living, a newly public company, has seen its stock rise 45% since its IPO, with analysts optimistic about its growth potential in the senior housing market, supporting its future market performance.
See More
2025 Medicare Risk Adjustment Impact on Insurers
- Molina's Impact: Baird estimates that Molina will incur an additional $11.2 million in payments, which, while minor, necessitates adjustments to its financial outlook and could affect future profitability.
- Centene and Oscar Performance: Following the latest government risk adjustment settlement, shares of Centene and Oscar Health rose by 6% and 12% respectively, reflecting market optimism about their financial health, particularly as Centene's Q4 commentary aligns with the new data.
- Risk Adjustment Mechanism Explained: The Medicare risk adjustment program redistributes funds among health insurers, aiding those with sicker customers, and the latest report confirms the final settlement data for 2025, impacting insurers' earnings.
- Retail Trader Sentiment: Despite CNC, MOH, and OSCR retail sentiment remaining neutral, CNC has gained 66% year-to-date while OSCR has surged 122%, indicating ongoing investor interest and confidence in these stocks.
See More
Oscar Health CEO's Stock Sale Sparks Price Surge
- Stock Sale Overview: Oscar Health CEO Mark T. Bertolini sold 1.24 million Class A shares worth approximately $35.7 million, leading to a stock price increase of about 12.23% during the session, reaching a new 52-week high of $32.06 before closing at $31.90, indicating a positive market reaction to the sale.
- Reason for Transactions: The SEC Form 4 filing revealed that the transactions were entirely non-discretionary, aimed at covering tax obligations related to the deferred settlement of PSUs that vested on April 3, 2026, rather than reflecting a change in management's outlook on the company.
- Market Reaction: Investors interpreted the filing as confirmation that the entire $35.7 million selling program had been completed, alleviating potential overhang on the stock and further boosting market confidence in Oscar Health, contributing to its price surge.
- Year-to-Date Performance Comparison: Oscar Health's stock has surged 121.99% year-to-date, significantly outperforming the S&P 500's 9.60% return, showcasing its strong market performance, with a current Strong Buy rating of 4.92 reflecting analysts' optimism about its future prospects.
See More
Oscar Health: Disruptor in the Health Insurance Market
- Massive Market Potential: The U.S. healthcare industry spends trillions annually, with growth expected to outpace inflation due to an aging population, presenting significant opportunities for innovative companies like Oscar Health.
- Customer Base Expansion: Oscar Health has grown its customer count to 3.2 million over the past few years, establishing itself as a major player in the ACA marketplace, demonstrating its ability to stand out among traditional insurers with substantial growth potential ahead.
- Record Revenue Guidance: Oscar Health anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record figures for the company, indicating its success in leveraging network effects and customer growth.
- Significant Profit Potential: If Oscar Health doubles its customer base to 6.5 million over the next five years, its 2026 premium revenue could reach $50 billion, with a 5% operating margin translating to $2.5 billion in annual operating income, highlighting the investment value of its stock.
See More
Oscar Health's Massive Profit Potential by 2026
- Market Share Growth: Oscar Health has reached 3.2 million customers this year, establishing itself as a major player in the ACA marketplace, indicating a competitive edge over traditional health insurers and expected continued market share expansion.
- Revenue Guidance Innovation: The company anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record highs, indicating a significant improvement in profitability within the health insurance sector.
- Enhanced Customer Experience: By offering free telehealth services and dedicated online customer support, Oscar Health has achieved customer satisfaction levels significantly higher than traditional insurers, which is expected to attract new clients and enhance customer loyalty.
- Long-Term Growth Potential: If the customer base doubles to 6.5 million over the next five years, premium revenue could reach $50 billion by 2026, potentially generating $2.5 billion in annual operating income at a 5% margin, highlighting the investment value of its stock.
See More
Applied Materials Opens $500M Singapore Campus, Hits 52-Week High
- Manufacturing Expansion: Applied Materials opened its $500 million Tampines Campus in Singapore, leading its stock to reach a 52-week high of $534.44 on Wednesday, with the new facility more than doubling cleanroom space and helping semiconductor manufacturers meet the growing demand from AI-related technologies, thereby enhancing the company's future growth potential.
- Telecom Technology Milestone: AmpliTech shares climbed to a five-year high of $8.29 after successfully participating in the O-RAN ALLIANCE Global PlugFest, where its advanced radio technology demonstrated interoperability with major telecommunications operators' equipment, marking a significant step toward broader commercial adoption of its 5G infrastructure products and strengthening its position within the Open RAN ecosystem.
- Analyst Rating Upgrade: Oscar Health received support from Barclays analyst Andrew Mok, who upgraded the stock from 'Equal Weight' to 'Overweight' and raised the price target from $30 to $35, noting that Oscar provides investors with a direct way to benefit from growth in the Affordable Care Act insurance market, with greater gains expected if demand for ACA plans continues to rise.
- Strong Market Performance: Despite a broader market pause, shares of Applied Materials, AmpliTech, and Oscar Health all reached new 52-week highs on Wednesday, with AMAT and OSCR stocks surging 93% year-to-date, while AMPG stock jumped over 154%, reflecting strong investor confidence in the future growth of these companies.
See More
Healthcare Sector Rally: Raymond James Picks New Stars
- Healthcare Sector Rally: The healthcare sector surged over 6% in June as investors shifted towards defensive plays, reflecting strong interest in healthcare stocks amid poor performance in tech stocks.
- UnitedHealth Group's Strong Performance: UnitedHealth's stock has risen 28%, with expectations for near-term gains from its earnings report on July 16, driven by moderating medical cost trends and improving insurance margins.
- Dividend Growth and Analyst Ratings: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, with 80% of analysts rating it a buy, although the consensus price target suggests a potential 3% decline over the next year.
- Emerging Opportunities for Janus Living: Janus Living, a newly public company, has seen its stock rise 45% since its IPO, with analysts optimistic about its growth potential in the senior housing market, supporting its future market performance.
See More
2025 Medicare Risk Adjustment Impact on Insurers
- Molina's Impact: Baird estimates that Molina will incur an additional $11.2 million in payments, which, while minor, necessitates adjustments to its financial outlook and could affect future profitability.
- Centene and Oscar Performance: Following the latest government risk adjustment settlement, shares of Centene and Oscar Health rose by 6% and 12% respectively, reflecting market optimism about their financial health, particularly as Centene's Q4 commentary aligns with the new data.
- Risk Adjustment Mechanism Explained: The Medicare risk adjustment program redistributes funds among health insurers, aiding those with sicker customers, and the latest report confirms the final settlement data for 2025, impacting insurers' earnings.
- Retail Trader Sentiment: Despite CNC, MOH, and OSCR retail sentiment remaining neutral, CNC has gained 66% year-to-date while OSCR has surged 122%, indicating ongoing investor interest and confidence in these stocks.
See More
Oscar Health CEO's Stock Sale Sparks Price Surge
- Stock Sale Overview: Oscar Health CEO Mark T. Bertolini sold 1.24 million Class A shares worth approximately $35.7 million, leading to a stock price increase of about 12.23% during the session, reaching a new 52-week high of $32.06 before closing at $31.90, indicating a positive market reaction to the sale.
- Reason for Transactions: The SEC Form 4 filing revealed that the transactions were entirely non-discretionary, aimed at covering tax obligations related to the deferred settlement of PSUs that vested on April 3, 2026, rather than reflecting a change in management's outlook on the company.
- Market Reaction: Investors interpreted the filing as confirmation that the entire $35.7 million selling program had been completed, alleviating potential overhang on the stock and further boosting market confidence in Oscar Health, contributing to its price surge.
- Year-to-Date Performance Comparison: Oscar Health's stock has surged 121.99% year-to-date, significantly outperforming the S&P 500's 9.60% return, showcasing its strong market performance, with a current Strong Buy rating of 4.92 reflecting analysts' optimism about its future prospects.
See More
Oscar Health: Disruptor in the Health Insurance Market
- Massive Market Potential: The U.S. healthcare industry spends trillions annually, with growth expected to outpace inflation due to an aging population, presenting significant opportunities for innovative companies like Oscar Health.
- Customer Base Expansion: Oscar Health has grown its customer count to 3.2 million over the past few years, establishing itself as a major player in the ACA marketplace, demonstrating its ability to stand out among traditional insurers with substantial growth potential ahead.
- Record Revenue Guidance: Oscar Health anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record figures for the company, indicating its success in leveraging network effects and customer growth.
- Significant Profit Potential: If Oscar Health doubles its customer base to 6.5 million over the next five years, its 2026 premium revenue could reach $50 billion, with a 5% operating margin translating to $2.5 billion in annual operating income, highlighting the investment value of its stock.
See More
Oscar Health's Massive Profit Potential by 2026
- Market Share Growth: Oscar Health has reached 3.2 million customers this year, establishing itself as a major player in the ACA marketplace, indicating a competitive edge over traditional health insurers and expected continued market share expansion.
- Revenue Guidance Innovation: The company anticipates reaching $19 billion in revenue and $450 million in operating income by 2026, both record highs, indicating a significant improvement in profitability within the health insurance sector.
- Enhanced Customer Experience: By offering free telehealth services and dedicated online customer support, Oscar Health has achieved customer satisfaction levels significantly higher than traditional insurers, which is expected to attract new clients and enhance customer loyalty.
- Long-Term Growth Potential: If the customer base doubles to 6.5 million over the next five years, premium revenue could reach $50 billion by 2026, potentially generating $2.5 billion in annual operating income at a 5% margin, highlighting the investment value of its stock.
See More
Applied Materials Opens $500M Singapore Campus, Hits 52-Week High
- Manufacturing Expansion: Applied Materials opened its $500 million Tampines Campus in Singapore, leading its stock to reach a 52-week high of $534.44 on Wednesday, with the new facility more than doubling cleanroom space and helping semiconductor manufacturers meet the growing demand from AI-related technologies, thereby enhancing the company's future growth potential.
- Telecom Technology Milestone: AmpliTech shares climbed to a five-year high of $8.29 after successfully participating in the O-RAN ALLIANCE Global PlugFest, where its advanced radio technology demonstrated interoperability with major telecommunications operators' equipment, marking a significant step toward broader commercial adoption of its 5G infrastructure products and strengthening its position within the Open RAN ecosystem.
- Analyst Rating Upgrade: Oscar Health received support from Barclays analyst Andrew Mok, who upgraded the stock from 'Equal Weight' to 'Overweight' and raised the price target from $30 to $35, noting that Oscar provides investors with a direct way to benefit from growth in the Affordable Care Act insurance market, with greater gains expected if demand for ACA plans continues to rise.
- Strong Market Performance: Despite a broader market pause, shares of Applied Materials, AmpliTech, and Oscar Health all reached new 52-week highs on Wednesday, with AMAT and OSCR stocks surging 93% year-to-date, while AMPG stock jumped over 154%, reflecting strong investor confidence in the future growth of these companies.
See More
